Amyloid β Proteoforms Elucidated by Quantitative LC/MS in the 5xFAD Mouse Model of Alzheimer’s Disease
- 17 October 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 22 (11) , 3475-3488
Abstract
Numerous Aβ proteoforms, identified in the human brain, possess differential neurotoxic and aggregation propensities. These proteoforms contribute in unknown ways to the conformations and resultant pathogenicity of oligomers, protofibrils, and fibrils in Alzheimer's disease (AD) manifestation owing to the lack of molecular-level specificity to the exact chemical composition of underlying protein products with widespread interrogating techniques, like immunoassays. We evaluated Aβ proteoform flux using quantitative top-down mass spectrometry (TDMS) in a well-studied 5xFAD mouse model of age-dependent Aβ-amyloidosis. Though the brain-derived Aβ proteoform landscape is largely occupied by Aβ1-42, 25 different forms of Aβ with differential solubility were identified. These proteoforms fall into three natural groups defined by hierarchical clustering of expression levels in the context of mouse age and proteoform solubility, with each group sharing physiochemical properties associated with either N/C-terminal truncations or both. Overall, the TDMS workflow outlined may hold tremendous potential for investigating proteoform-level relationships between insoluble fibrils and soluble Aβ, including low-molecular-weight oligomers hypothesized to serve as the key drivers of neurotoxicity. Similarly, the workflow may also help to validate the utility of AD-relevant animal models to recapitulate amyloidosis mechanisms or possibly explain disconnects observed in therapeutic efficacy in animal models vs humans.Keywords
Funding Information
- AbbVie
- National Institute on Aging (RF1 AG063903)
- National Institute of General Medical Sciences (GM108569)
This publication has 86 references indexed in Scilit:
- Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activationMolecular Neurodegeneration, 2013
- Antioxidants for Alzheimer DiseaseArchives of Neurology, 2012
- The amyloid-β isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer's diseaseMolecular Medicine Reports, 2012
- Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s diseaseActa Neuropathologica, 2010
- Comparison of Alzheimer Aβ(1–40) and Aβ(1–42) amyloid fibrils reveals similar protofilament structuresProceedings of the National Academy of Sciences, 2009
- Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s diseaseBiomarkers, 2009
- The Oxidative Stress Metabolite 4-Hydroxynonenal Promotes Alzheimer Protofibril FormationBiochemistry, 2007
- Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivoNature Medicine, 2006
- 3D structure of Alzheimer's amyloid-β(1–42) fibrilsProceedings of the National Academy of Sciences, 2005
- Isolation, Chemical Characterization, and Quantitation of Aβ 3-Pyroglutamyl Peptide from Neuritic Plaques and Vascular Amyloid DepositsBiochemical and Biophysical Research Communications, 1997